文献速递脑血管病外科

WEB装置单独治疗破裂与未破裂颅内动脉瘤:47例回顾性分析

WEB-only treatment of ruptured and unruptured intracranial aneurysms: a retrospective analysis of 47 aneurysms.
PubMed 文献 · Acta Neurochir (Wien) · 2019-06-25

单中心回顾性研究纳入2013年4月至2018年7月间仅用WEB装置治疗且随访至少3个月的47个颅内动脉瘤(破裂12个,25.5%),评估随访血管造影结果、围手术期并发症率和再治疗率。结果显示 adequate occlusion 达91.4%,再治疗率6.3%,血栓栓塞事件12.7%,出血并发症4.2%。结论认为WEB可实现 adequate occlusion 且多无需长期抗血小板治疗,尤其适用于宽颈动脉瘤,但适应证可扩展至窄颈、小型及侧壁动脉瘤。

要点

  • WEB单药治疗47个动脉瘤,adequate occlusion 率91.4%,再治疗率6.3%。
  • 血栓栓塞事件12.7%,出血并发症4.2%,破裂者出血并发症更高(16.6%)。
  • WEB多无需长期抗血小板治疗,尤其适用于宽颈动脉瘤。

核心结论

  • WEB装置单独治疗破裂和未破裂颅内动脉瘤可实现较高的 adequate occlusion 率,且多无需长期抗血小板治疗。
  • WEB的获益尤其见于宽颈动脉瘤,但适应证可扩展至窄颈、小型和侧壁动脉瘤。

研究设计与样本

  • 单中心回顾性研究,纳入2013年4月至2018年7月间仅用WEB装置治疗且随访至少3个月的47个颅内动脉瘤。

主要发现

  • 动脉瘤平均大小为6.3 mm(破裂5.4 mm,未破裂6.6 mm),中位随访9个月。
  • 完全闭塞26/47(55.3%;破裂66.6%,未破裂51.4%),瘤颈残留13/47(27.6%;破裂16.6%,未破裂31.4%)。
  • WEB内持续对比增强4/47(8.5%;破裂8%,未破裂8.5%),动脉瘤残留4/47(8.5%;破裂8%,未破裂8.5%)。
  • Adequate occlusion(完全闭塞+瘤颈残留)43/47(91.4%;破裂91.6%,未破裂91.4%)。
  • 再治疗率6.3%(破裂8%,未破裂5.7%);血栓栓塞事件6例(12.7%;破裂25%,未破裂8.5%);出血并发症2例(4.2%;破裂16.6%,未破裂0%)。

临床怎么用

  • WEB可作为破裂和未破裂颅内动脉瘤的血管内治疗选择,尤其适用于宽颈动脉瘤。
  • WEB治疗多无需长期抗血小板治疗,但需注意血栓栓塞事件(12.7%)和出血并发症(4.2%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: WEB (Woven EndoBridge) device is an intrasaccular flow diverter designed for endovascular treatment of intracranial aneurysms. Recent clinical trials showed good feasibility, safety, and efficacy profiles. In most of the published studies however, aneurysms treated with adjunctive devices other than WEB such as coils or stents were included which might make it difficult to reflect the real potential of this device. The purpose of this single-center study was to present the results of ruptured and unruptured aneurysms treated only with WEB device. METHOD: Between April 2013 and July 2018, 47 (ruptured, 12; 25.5%) intracranial aneurysms treated only with WEB and a follow-up of at least 3 months were included in the study. Angiographic outcome at follow-up, peri-procedural complication rate, and rate of retreatment were recorded. RESULTS: Of the 47 aneurysms, 12 (25.5%) were ruptured. The mean size of the aneurysms was 6.3 mm (ruptured, 5.4 mm; unruptured, 6.6 mm). Median follow-up period was 9 months. Complete occlusion was observed in 26/47 aneurysms (55.3%; ruptured, 66.6%; unruptured, 51.4%). Thirteen aneurysms (27.6%; ruptured, 16.6%; unruptured, 31.4%) showed a neck remnant. In 4/47 aneurysms (8.5%; ruptured, 8%; unruptured, 8.5%), persistent contrast enhancement inside the WEB was recorded. In 4/47 patients (8.5%; ruptured, 8%; unruptured, 8.5%), an aneurysm remnant was noted. Adequate occlusion (complete occlusion and neck remnant) was observed in 43/47 aneurysms (91.4%; ruptured, 91.6%; unruptured, 91.4%). Retreatment rate was 6.3% (ruptured, 8%; unruptured, 5.7%). Six (12.7%; ruptured, 25%; unruptured, 8.5%) thromboembolic events were recorded. Hemorrhagic complications occurred in two patients (4.2%; ruptured, 16.6%; unruptured, 0%). CONCLUSIONS: WEB enables adequate occlusion of ruptured and unruptured intracranial aneurysms mostly without requirement of long-term antiplatelet therapy. The benefit is seen especially by the wide-necked aneurysms, but indications should be extended to include narrow-necked, smaller, and side-wall aneurysms.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Ozpeynirci Y, Braun M, Pala A, et al. WEB-only treatment of ruptured and unruptured intracranial aneurysms: a retrospective analysis of 47 aneurysms. Acta Neurochir (Wien). 2019. PMID: 31240584. doi:10.1007/s00701-019-03988-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。